Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
Year: 2006
Type: article
Source: Journal of Leukocyte Biology
DOI: 10.1189/jlb.0306173
Institutions: IRCCS Ospedale San Raffaele, Scripps Research Institute
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1985528704
